In a groundbreaking new study that pushes the boundaries of our understanding of human longevity, researchers from the Josep Carreras Leukaemia Research Institute have unlocked unprecedented insights into the biology of aging by analyzing the longest-lived person ever recorded: Maria Branyas, a Catalan woman who surpassed 117 years of age. This multi-omic investigation, integrating genomic, proteomic, epigenomic, metabolomic, and microbiomic data, presents the most comprehensive molecular portrait of extreme human lifespan to date, shedding light on the intricate balance between aging and health that defines supercentenarian biology.
For over two centuries, life expectancy steadily increased, propelled by advances in medicine, sanitation, and public health. However, recent epidemiological data indicate that this upward trajectory has plateaued in developed countries. The implications are profound, suggesting that the conventional approaches to extending lifespan may have reached a limit, emphasizing the necessity to rethink aging not merely as a byproduct of disease but as a fundamental biological process. This study directly addresses this paradigm shift by dissecting aging in its purest form, distinct from pathological conditions.
Dr. Manel Esteller and his team employed cutting-edge multi-omic technologies to paint a detailed molecular picture of this supercentenarian. Crucially, the study’s minimally invasive sampling allowed for extensive biological characterization without compromising the integrity of this precious subject. The integration of various data layers—ranging from chromosomal integrity and gene expression to systemic metabolic and microbial profiles—provides a holistic view that transcends traditional single-omics studies, capturing the coexistence of ageing markers and indicators of sustained physiological resilience.
Surprisingly, their findings reveal a paradoxical duality underlying extreme longevity. While unmistakable hallmarks of aging—such as critically shortened telomeres, a hallmark of chromosomal decay, and a systemic pro-inflammatory immune signature—were clearly present, they coexisted with a set of protective molecular features that may mitigate age-related decline. These include genetic variants associated with neuroprotection and cardioprotection, which presumably confer resilience to neurodegenerative and cardiovascular disorders commonly linked with advanced age.
Another remarkable aspect of Maria Branyas’s biological profile was the demonstration of a biologically younger epigenetic age in contrast to her chronological age. This discovery, quantified using DNA methylation clocks, suggests that specific epigenetic modifications can decouple biological aging from calendar time. This delayed epigenetic aging may be key to her exceptional health span, indicating that biological age could serve as a more accurate biomarker for health and longevity than traditional chronological age.
Moreover, the composition of her gut microbiome was dominated by beneficial bifidobacteria, microorganisms known for their role in modulating immune function and metabolic health. The prominence of such microbial populations aligns with emerging evidence linking microbiome diversity and stability to healthy aging, possibly influencing systemic inflammation and nutrient absorption. Maintaining a balanced microbiota may thus be an essential component in fostering longevity and reducing age-associated morbidity.
The study also highlights the aging of the hematopoietic system – the blood and immune system – which is intimately tied to increased risks of blood cancers like leukemia and myelodysplastic syndromes. The insights drawn from examining Maria Branyas’s blood cellular profile deepen our understanding of hematological aging and suggest potential avenues for preventive strategies or therapeutics targeting immune senescence and oncogenesis in the elderly.
Perhaps most strikingly, this research delineates, for the first time in scientific literature, the biological processes of aging from the development of illness. The subject’s absence of significant pathology allows a rare glimpse into true aging biology, unconfounded by disease effects, providing a blueprint for detecting healthy aging patterns distinct from disease-driven decline. This clarity opens new opportunities for interventions aiming to delay aging effects rather than solely treating associated illnesses.
While the study refrains from attributing causality to specific lifestyle factors, it acknowledges that Mrs. Branyas’s exceptional longevity likely results from a confluence of her dietary habits, rich social network, and avoidance of toxic behaviors such as smoking. These observations are congruent with wider epidemiological data supporting the influence of environment and behavior in modulating aging processes.
Looking forward, the knowledge generated here catalyzes further research into therapeutic strategies for age-associated decline. Epigenetic therapies, already used in oncology to modulate gene expression and combat senescence, emerge as promising candidates to be repurposed for rejuvenation medicine. With aging now recognized as a tractable biological target, such interventions could rekindle the stalled increase in human life expectancy by directly addressing the cellular and molecular underpinnings of aging.
This exceptional multi-disciplinary endeavor is not only a landmark in aging research but also an inspiration for an integrative approach to studying human biology. By leveraging the latest high-throughput technologies and computational methods, the team at the Josep Carreras Institute exemplifies how comprehensive biological data can transform our understanding of the most intricate phenomena—human longevity itself.
Funded by prominent institutions including the Generalitat de Catalunya, the European Community, and the Spanish Ministry of Science, alongside private foundations, this work reflects an international commitment to unravel mechanisms of aging and develop translational pathways to enhance healthspan. Its publication in Cell Reports Medicine ensures broad dissemination within the scientific community, paving the way for future studies that will build upon this pioneering blueprint of extreme human lifespan.
As society grapples with aging populations and increasing healthcare burdens, the findings from Maria Branyas’s biological legacy offer hope that aging, long considered an inexorable decline, may one day be controlled, postponed, or deeply understood. The molecular duality documented here underscores that aging does not equate to inevitable deterioration but may instead be a complex, modifiable process—one that science is just beginning to decode.
Subject of Research: Cells
Article Title: “The multiomics blueprint of the individual with the most extreme lifespan”.
News Publication Date: 24-Sep-2025
Image Credits: Josep Carreras Leukaemia Research Institute
Keywords: Epigenetics, Leukemia, Blood diseases, Aging populations
Tags: aging as a biological processbiological characterization of agingextreme human lifespan explorationgenomic and proteomic aging studiesimplications of life expectancy plateauinnovative approaches to longevityJosep Carreras Leukaemia Research Institute findingslongevity research breakthroughsMaria Branyas longevity studymulti-omic analysis of agingrethinking aging and healthsupercentenarian biology insights
